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CASE REPORT
Many physicians are unfamiliar with African tick
bite fever (ATBF), a rickettsiosis caused by Rickettsia
africae1 and transmitted by ticks in rural sub-
Saharan Africa. We report the case of a patient who
was infected with ATBF whilst in South Africa.
Case Report
A 62-year-old Taiwanese woman presented with
fever and two mild tender skin nodules 5 days
after returning from a 2-week trip to South Africa.
She denied a history of insect bites or close con-
tact with animals. There were two erythematous
pustular nodules on her left inner thigh and left
shoulder. Oral cephalexin was prescribed for pre-
sumed furunculosis. However, 10 days later, the
nodules became two black eschars, about 1 cm in
diameter (Figures 1A and 1B), and with scattered
2–3-mm asymptomatic erythematous papules and
vesicles near the eschars (Figures 1C and 1D).
She also had a low-grade fever but no myalgias
or lymphadenopathy.
Histologically, an eschar specimen had wedge-
shaped tissue necrosis and diffuse inflammation
extending to the subcutis (Figure 2A). There was
necrotizing vasculitis of small venules and arteri-
oles with a dense perivascular lymphocytic in-
filtrate and hemorrhage (Figure 2B). Gram and
periodic acid-Schiff stains were negative for bac-
teria and fungi. Serial indirect immunofluorescence
serology for rickettsiae by the Taiwan Centers for
Disease Control found a four-fold increase (160−
1280×) in immunoglobulin G titers for both 
R. rickettsii and R. conorii, but was negative for
other rickettsioses.
Nested polymerase chain reaction (PCR) of
eschar material was performed as previously de-
scribed.1 The first suicide PCR assay used the
primers AF3F, AF3R, AF4F and AF4R for nested
amplification (Figure 3). The PCR product was
then amplified by using AF5F, AF5R, AF6F and
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AF6R as second primers. The PCR product was
then sequenced by restriction fragment length
polymorphism and found to be homologous to
R. africae DNA.
Initial treatment before confirmation of the
diagnosis included ceftazidime, ciprofloxacin and
minocycline, but ceftazidime was discontinued
once ATBF was diagnosed. The patient had al-
ready received a total of 14 days of ciprofloxacin
and minocycline before the diagnosis was made.
She recovered without sequelae other than hy-
perpigmented scars at the eschar sites. None of the




Figure 1. Black eschars on the (A) left shoulder and (B) left thigh, with a few surrounding red papules. (C) Erythematous
papule on dorsal foot. (D) Vesicle in the axilla.
Figure 2. (A) Histopathologic examination shows wedge-shaped tissue necrosis deep in the subcutis (hematoxylin &
eosin, 40×). (B) Necrotizing vasculitis of small venules with perivascular lymphocytic infiltration with some leukocytes,
nuclear dust and hemorrhage (hematoxylin & eosin, 400×).
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Discussion
Rickettsioses can be transmitted by ticks, mites,
fleas or lice. ATBF, caused by R. africae, and Medi-
terranean spotted fever, caused by R. conorii, are the
most common tick-born rickettsioses associated
with international travel over the last decade.1
ATBF is transmitted by Amblyomma hebraeum and
A. variegatum.2 The risk of this infection is partic-
ularly high from November to April in rural sub-
Saharan Africa.2–4
All physicians need to be familiar with rick-
ettsioses because patients may present with vari-
ous symptoms. Rashes are common and may 
be recognized first; they are usually characterized
by diffuse or scattered blanching erythematous
macules, papules, vesicles, petechiae or purpura.
A cigarette burn-like eschar at the site of the vec-
tor bite may be present in some. Very similar
clinical manifestations are present in the spotted
fever group of rickettsioses (including both Rocky
Mountain and Mediterranean spotted fever) and
the typhus group, such as scrub typhus.5,6 Scrub
typhus, endemic in Eastern Taiwan and caused
by Orientia tsutsugamushi, may also present with
eschar, scattered erythematous macules, papules,
vesicles or patches.6 However, ATBF is somewhat
unusual in that the ticks that transmit it are quite
aggressive. In contrast to other rickettsioses, there-
fore, about one quarter to one half of patients
with ABTF have multiple eschars,2 a pathog-
nomonic sign. The rash in ATBF is usually more
papular and vesicular than purpuric. With this
constellation of skin signs, therefore, it is possible
for physicians to tentatively diagnose ATBF even
before the serology results are available, espe-
cially if it occurs in a cluster of people who have
traveled from an endemic area such as South
Africa, Botswana and Zimbabwe.4,7–9
The diagnosis can be made without difficulty
with serologic tests for R. africae. The specific an-
tibody is usually not accessible in non-endemic
areas, however. The organism is antigenically sim-
ilar to R. conorii and may show cross reactivity to
different species in the spotted fever group, such
as R. rickettsii (which causes Rocky Mountain spot-
ted fever) and R. conorii. Our patient had this
cross-reactivity. This possibility should be kept 
in mind, therefore, and ATBF should be included
in the differential diagnosis when there is a history
consistent with exposure. Suggested diagnostic
criteria for patients with a flu-like illness com-
mencing no later than 10 days after leaving rural
sub-Saharan Africa include: (1) direct evidence
of R. africae infection by culture and/or PCR; (2)










Figure 3. Agarose gel electrophoresis of the DNA fragments obtained by nested polymerase chain reaction of the eschar
specimen. Lanes 1, 3, 6, 8 = eschar specimens; lanes 2, 4, 7, 9 = negative control; lanes 5, 10 = DNA ladder.
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Western blot with or without cross-adsorption
assays; or (3) serology specific for recent spotted
fever group rickettsial infection plus clinical and
epidemiologic features consistent with ATBF, such
as multiple inoculation eschars, eschar plus a vesic-
ular cutaneous rash, or clustering of cases.10
Histologic examination is helpful but not 
diagnostic. Papular lesions in ATBF often have
necrotizing vasculitis with perivascular infiltrates
composed mostly of lymphocytes and macro-
phages, luminal thrombosis, and microinfarcts.11
The eschars are characterized by wedge-shaped epi-
dermal and dermal necrosis. It has been reported
that the vasculitis in ATBF contains significantly
more polymorphonuclear leukocytes than that of
Mediterranean spotted fever,12 although we did
not find this to be true in our patient. The eschar
contains the most organisms and is therefore the
best specimen for PCR.2 Identification of R. africae
by this method yields a definitive diagnosis.
ATBF usually has a benign clinical course,
with no deaths reported as yet,5 compared to
scrub typhus that may have severe systemic symp-
toms or complications, such as meningitis, hepa-
titis or renal failure.6 Rare complications have,
however, occurred in ATBF, including acute myo-
carditis,13 subacute neuropathy,14 temporary neu-
ropsychiatric symptoms,15 and reactive arthritis.3
Treatment is similar to that for other rickettsial
infections, i.e. with tetracycline, quinolones or
chloramphenicol.11
In conclusion, physicians should be aware of
ATBF. A careful search should be made for the
characteristic eschars in patients with a history of
travel to endemic areas.
Acknowledgments
This work was supported by a grant (MMH-9150-
66) from Mackay Memorial Hospital, Taiwan.
References
1. Jensenius M, Fournier PE, Raoult D. Tick-borne rick-
ettsioses in international travellers. Int J Infect Dis 2004;
8:139–46.
2. Jensenius M, Fournier PE, Kelly P, et al. African tick bite
fever. Lancet Infect Dis 2003;3:557–64.
3. Jensenius M, Fournier PE, Vene Sirkka, et al. African 
tick bite fever in traveler to rural sub-equatorial Africa.
Clin Infect Dis 2003;36:1411–7.
4. Caruso G, Zasio C, Guzzo F, et al. Outbreak of African 
tick-bite fever in six Italian tourists returning from South
Africa. Eur J Clin Microbiol Infect Dis 2002;21:133–6.
5. Jensenius M, Fournier PE, Raoult D. Rickettsioses and the
international traveler. Clin Infect Dis 2004;39:1493–9.
6. Wu YH, Su HY. Cutaneous manifestations of scrub typhus.
Dermatol Sinica 1998;16:251–60.
7. Consigny PH, Rolain JM, Mizzi D, et al. African tick-
bite fever in French travelers. Emer Inf Dis 2005;11:
1804–6.
8. Fournier PE, Roux V, Caumes E, et al. Outbreak of Rickettsia
africae infections in participants of an adventure race in
South Africa. Clin Infect Dis 1998;27:316–23.
9. McQuiston JH, Paddock CD, Singleton J Jr, et al. Imported
spotted fever rickettsioses in United States travelers 
returning from Africa: a summary of cases confirmed by
laboratory testing at the Centers for Disease Control and
Prevention, 1999–2002. Am J Trop Med Hyg 2004;70:
98–101.
10. Jensenius M, Fournier PE, Hellum KB, et al. Sequential
changes in hematologic and biochemical parameters in
African tick bite fever. Clin Microbiol Infect 2003;9:
678–83.
11. Toutous-Trellu L, Peter O, Chavaz P, et al. African tick bite
fever: not a spotless rickettsiosis J Am Acad Dermatol
2003;48:S18–9.
12. Lepidi H, Fournier PE, Raoult D. Histologic features and
immunodetection of African tick-bite fever eschar. Emerg
Inf Dis 2006;12:1332–7.
13. Bellini C, Monti M, Potin M, et al. Cardiac involvement in
a patient with clinical and serological evidence of African
tick-bite fever. BMC Infect Dis 2005;5:90.
14. Jensenius M, Fournier PE, Fladby T, et al. Sub-acute 
neuropathy in patients with African tick bite fever. Scand 
J Infect Dis 2006;38:114–8.
15. Jackson Y, Chappuis F, Loutan L. African tick-bite fever:
four cases among Swiss travelers returning from South
Africa. J Travel Med 2004;11:225–8.
